Please assess the completion status of the following clinical trial:

Trial Title: Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of advanced non-small cell lung cancer~* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1~Exclusion Criteria:~* Any prior treatment for non-small cell lung cancer~* Brain metastases~* With diabetes

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 74 Years
- Healthy Volunteers: f

Study Arms:
- CP-751,871 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).